Search results
Results From The WOW.Com Content Network
Beers criteria. The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
Institutions. University of California, Los Angeles. Mark Howard Beers (April 24, 1954 – February 28, 2009) [1] was an American geriatrician whose research on drug interactions among the elderly led to the creation of the eponymous Beers criteria, which lists prescription medications that may have deleterious side effects in older patients.
American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012). "American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults" . Journal of the American Geriatrics Society .
The use of polypharmacy is correlated to the use of potentially inappropriate medications. Potentially inappropriate medications are generally taken to mean those that have been agreed upon by expert consensus, such as by the Beers Criteria. These medications are generally inappropriate for older adults because the risks outweigh the benefits. [36]
A recent study published in the British Medical Journal, looked at a large sample of older adults ages 60 to 84. Participants were divided into two groups—one was given a placebo, while the ...
Deprescribing is a process of tapering or stopping medications to achieve improved health outcomes by reducing exposure to medications that are potentially either harmful or no longer required. [1] Deprescribing is important to consider with changing health and care goals over time, as well as polypharmacy and adverse effects. [2]
Choose Lighter Beers Beer can be high in carbohydrates (without the nutritional benefits of other healthy carbs ), ranging anywhere from 3 grams (g) to upwards of 25 grams per 12 ounces (oz).
Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia. [3] [4] Evidence supports slight to moderate benefit up to six months. [5] [4] [6] It is taken by mouth. [3] [5] Common side effects include headache, dry mouth, nausea, and dizziness. [5]